BSECompany Update23 Jun 2026 · 23 Jun 2026, 06:58 pm
Axis Capital Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Disclosure of number of Equity Shares tendered in connection with the captioned Open Offer to the Public Shareholder ....
Novartis India Ltd · 500672
✦ AI SummaryM&A
Novartis India Ltd announced an update on the open offer by WaveRise Investments Limited and other acquirers to acquire up to 26% of the company's voting share capital. As of June 23, 2026, a negligible number of shares (NIL in demat and 112 in physical form) have been tendered, representing 0.00% of the offer size. This indicates very low participation from public shareholders in the ongoing offer.
Analysis Scores
Earnings Impact5/10
Growth Catalyst4/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Novartis India Ltd - 500672 - Updates on Open Offer
Attachments (1)
📄pdf
Download →
2CE7BFF0-1B75-44CD-B4D4-E762F21AC38E-185815.pdf
View document text
June 23, 2026
BSE Limited
Phiroze Jeejeebhoy Towers,
Dalal Street,
Mumbai- 400001,
Maharashtra, India.
Dear Sir/ Madam,
Subject: Open offer for acquisition of up to 64,19,608 (sixty four lakhs nineteen thousand six hundred and eight)
fully paid-up equity shares of face value of INR 5 each (“Equity Shares”) from the Public Shareholders of
Novartis India Limited (“Target Company”), representing 26% of the ‘Voting Share Capital’ of the Target
Company by WaveRise Investments Limited (“Acquirer 1”), ChrysCapital Fund X, the first scheme of
ChrysCapital Trust I, a category II alternative investment fund registered with the Securities and Exchange
Board of India (“Acquirer 2”) and Two Infinity Partners (“Acquirer 3”) (Acquirer 1, Acquirer 2, and
Acquirer 3, collectively referred to as the “Acquirers”) along with ChrysCapital X, LLC (“PAC 1”) and
OceanEdge Investments Limited (“PAC 2”) (PAC 1 and PAC 2, collectively referred to as the “PACs”), in
their capacity as persons acting in concert with the Acquirers (“Open Offer”).
Re: Disclosure of number of Equity Shares tendered in connection with the captioned Open Offer.
Please note that in relation to the Open Offer:
(i) NIL Equity Shares, constituting NIL% of the Offer Size, have been tendered till June 23, 2026 in the Open Offer
Escrow Demat Account namely “MIIPL NOVARTIS INDIA LIMITED OPEN OFFER ESCROW DEMAT
ACCOUNT” opened with Ventura Securities Limited bearing depository participant identification number
IN303116 and the client identification number 15855051 (PAN: AAACH2914F) (the “Open Offer Escrow
Demat Account”), as per Open Offer Escrow Demat Account statement received by the Manager to the Open
Offer from Ventura Securities Limited; and
(ii) 112 Equity Shares, constituting 0.00% of the Offer Size, have been tendered till June 23, 2026 in the physical
form with the Registrar to the Open Offer, as per the email received by the Manager to the Open Offer from the
Registrar to the Open Offer.
It is hereby expressly clarified that the above disclosure reflects: (i) the Equity Shares in dematerialized form tendered by
the Public Shareholders in the Open Offer Escrow Demat Account as per the Open Offer Escrow Demat Account statement
received by the Manager to the Open Offer from Ventura Securities Limited; and (ii) physical Equity Shares received by
the Registrar to the Open Offer, communicated to the Manager to the Open Offer by the Registrar to the Open Offer via
email.
For avoidance of doubt, the Equity Shares tendered by the Public Shareholders shall be subject to validation and verification
of submission of the complete set of documents, as applicable. The Equity Shares “validly tendered” in the Open Offer
shall be accepted in accordance with the SEBI (SAST) Regulations and the Letter of Offer dated June 1, 2026 (“Letter
of Offer”). The aforementioned number of the Equity Shares tendered by the Public Shareholders may differ from
the number of the Equity Shares which will be accepted by the Acquirers in the Open Offer.
Capitalized terms used herein and not specifically defined shall have the same meaning as ascribed to them in the Letter of
Offer.
We request you to take the same on your records and upload it on your website for dissemination to the public.
Thanking You,
For and on behalf of Axis Capital Limited
Name: Pratik Pednekar
Designation: AVP
Axis Capital Limited, CIN No.: U64990MH2005PLC157853; Website: www.axiscapital.co.in
Registered Office: Axis House, 1st Floor, Pandurang Budhkar Marg, Worli, Mumbai - 400 025,
Tel. No.: +91-22-4325 1199; Fax: +91-22-4325 3000; SEBI Merchant Banker Reg. No.: INM000012029,
SEBI Reg. No.: Stockbroker - INZ000189931; Research Analyst - INH000002434; Member of: BSE, NSE & MSEI
Compliance Officer - Ms. Vilma Mathias Gangahar; Email Address: acl.compliance@axiscap.in